CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways

Journal article

Open access

Peer reviewed

Saudi journal of biological sciences, Vol.29(6), pp.103285-103285

01/06/2022

PMID: 35592740

Abstract

Akt

BRAFV600E

ERK

High throughput

Melanoma

Original

Resistance

Vemurafenib

url

https://doi.org/10.1016/j.sjbs.2022.103285View

Published (Version of record) Open

1 Record Views

Title: CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways
Creators - without role: Mesfer Al Shahrani - King Khalid University
Prasanna Rajagopalan - King Khalid University
Mohammad Abohassan - King Khalid University
Mohammad Alshahrani - King Khalid University
Yasser Alraey - King Khalid University
Publication Details: Saudi journal of biological sciences, Vol.29(6), pp.103285-103285
Publisher: Elsevier
Identifiers: 9922785208331
Academic Unit: King Khalid University
Language: English
Resource Type: Journal article